Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Learn the key factors to inspect when comparing funds, including costs, performance, and risk, to make informed investment choices.
18,912 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
When Beyond Meat posted its latest results, a sharp selloff followed. This article dissects why investors bailed beyo...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
After a rough stretch for tech shares, Micron stock bounced back, signaling a renewed interest in memory makers. This...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
A major tech partnership and improving chip demand helped Intel stock climb sharply on Thursday. This deep dive expla...
A surprising shift in mega-cap leadership had investors buzzing: SpaceX briefly topped Amazon in market value. This p...
Tilray Brands has evolved from a pure-play cannabis company into a diversified player. This guide breaks down what to...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Investors often chase compelling stories more than spreadsheets. This piece explores historical price dynamics and ho...